Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:55 pm Purchase | 2026-06-30 | 13G | VOR BIOPHARMA INC VOR | Venrock Healthcare Capital Partners III, L.P. | 5,676,370 9.900% | 592,493 (+11.65%) | Filing History |
| 2026-08-14 4:26 pm Unchanged | 2026-06-30 | 13G | VOR BIOPHARMA INC VOR | Frazier Life Sciences Public Fund L.P. | 2,258,001 4.200% | 0 (Unchanged) | Filing History |
| 2026-08-13 4:30 pm Sale | 2026-06-30 | 13G | VOR BIOPHARMA INC VOR | Verve Capital Limited | 3,410,892 6.300% | -1,588,380 (-31.77%) | Filing History |
| 2026-08-07 11:14 am Purchase | 2026-07-31 | 13G | VOR BIOPHARMA INC VOR | FMR LLC | 6,509,996 12.000% | 1,577,847 (+31.99%) | Filing History |
| 2026-08-06 10:43 am Purchase | 2026-06-30 | 13G | VOR BIOPHARMA INC VOR | FMR LLC | 4,932,149 9.100% | 3,392,479 (+220.34%) | Filing History |
| 2026-07-30 11:18 am Purchase | 2026-06-30 | 13G | VOR BIOPHARMA INC VOR | BlackRock Inc. BLK | 3,099,259 5.700% | 3,099,259 (New Position) | Filing History |
| 2026-07-21 4:55 pm Purchase | 2026-07-16 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 12,937,855 19.900% | 41,336 (+0.32%) | Filing History |
| 2026-05-15 4:30 pm Purchase | 2026-03-31 | 13G | VOR BIOPHARMA INC VOR | Venrock Healthcare Capital Partners III, L.P. | 5,083,877 9.900% | 2,867,802 (+129.41%) | Filing History |
| 2026-05-15 4:27 pm Purchase | 2026-03-31 | 13G | VOR BIOPHARMA INC VOR | Verve Capital Limited | 4,999,272 9.300% | 701,808 (+16.33%) | Filing History |
| 2026-05-06 4:16 pm Unchanged | 2026-03-31 | 13G | VOR BIOPHARMA INC VOR | Qiming Venture Partners VIII-HC L.P. | 1,089,767 2.000% | 0 (Unchanged) | Filing History |
| 2026-05-06 11:40 am Sale | 2026-03-31 | 13G | VOR BIOPHARMA INC VOR | FMR LLC | 1,539,670 3.200% | -986,500 (-39.05%) | Filing History |
| 2026-04-21 7:05 pm Purchase | 2026-04-20 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 12,896,519 19.900% | 157,495 (+1.24%) | Filing History |
| 2026-04-15 5:31 pm Purchase | 2026-04-14 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 12,739,024 19.900% | 184,382 (+1.47%) | Filing History |
| 2026-04-10 6:25 pm Purchase | 2026-04-09 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 12,554,642 19.900% | 154,936 (+1.25%) | Filing History |
| 2026-04-08 6:45 pm Purchase | 2026-04-06 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 12,399,706 19.900% | 212,182 (+1.74%) | Filing History |
| 2026-04-01 5:29 pm Purchase | 2026-03-30 | 13G | VOR BIOPHARMA INC VOR | TCG Crossover GP II, LLC | 5,673,078 10.500% | 5,673,078 (New Position) | Filing History |
| 2026-04-01 5:09 pm Purchase | 2026-03-30 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 12,187,524 19.900% | 3,164,456 (+35.07%) | Filing History |
| 2026-03-16 4:15 pm Purchase | 2026-03-12 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 9,023,068 19.900% | 3,611,547 (+66.74%) | Filing History |
| 2026-02-17 6:59 pm Purchase | 2025-12-31 | 13G | VOR BIOPHARMA INC VOR | Verve Capital Limited | 4,297,464 9.900% | 3,536,765 (+464.94%) | Filing History |
| 2026-02-17 6:22 pm Purchase | 2025-12-31 | 13G | VOR BIOPHARMA INC VOR | Venrock Healthcare Capital Partners III, L.P. | 2,216,075 9.900% | 1,455,376 (+191.32%) | Filing History |